📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Pathogenesis of Systemic Sclerosis. (2015)

First Author: Stern EP

Attributed to: MICA: Evaluation of the selective endothelin A-receptor antagonist zibotentan as a treatment for renal disease in systemic sclerosis (scleroderma) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.rdc.2015.04.002

PubMed Identifier: 26210124

Publication URI: http://europepmc.org/abstract/MED/26210124

Type: Journal Article/Review

Volume: 41

Parent Publication: Rheumatic diseases clinics of North America

Issue: 3

ISSN: 0889-857X